U.S. approves Johnson & Johnson COVID vaccine plant

The FDA issued an Emergency Use Authorization for a Catalent Pharma plant in Bloomington, Indiana, allowing it to produce and ship doses of Johnson & Johnson’s coronavirus vaccine, the company announced Tuesday.

Why it matters: The plant will help J&J increase COVID vaccine shipments this spring and eventually fulfill the 200 million doses the pharmaceutical company agreed to deliver to the United States, according to Bloomberg.